Press release
Surge in the Global Non-Steroidal Anti-Inflammatory Drugs Market: A Comprehensive Review of Market Size, Market Share, Growth Drivers, and Upcoming Trends
Surge in the Global Non-Steroidal Anti-Inflammatory Drugs Market
Witness the accelerated growth of the Non-Steroidal Anti-Inflammatory Drugs Market projected to reach $22.1 billion in 2025 with a noteworthy compound annual growth rate (CAGR) of 6.8%.
What Is The Projected Market Size Of The Global Non-Steroidal Anti-inflammatory Drugs Market And Its Growth Rate?
• The market size of non-steroidal anti-inflammatory drugs grew significantly in recent years. It will grow from $20.68 billion in 2024 to $22.1 billion in 2025, exhibiting a CAGR of 6.8%.
• Factors contributing to this historic growth encompass chronic inflammatory diseases, postoperative pain management, sports injuries, over-the-counter availability, aging population, and heightened consumer awareness.
• The market size is expected to continue growing, reaching $28.79 billion in 2029 with a CAGR of 6.8%.
• This forecasted growth is driven by emerging pain management therapies, regulatory changes, telehealth utilization, global wellness trends, competition from biosimilars, patient preferences, and precision medicine approaches.
What Is Driving The Growth In The Non-Steroidal Anti-inflammatory Drugs Market?
The significant rise in chronic pain incidence is catalyzing the expansion of the non-steroidal anti-inflammatory drugs market. Chronic pain, persisting for over six months, is frequently caused by arthritis as reported by the CDC (Centers for Disease Control and Prevention), impacting millions in the US alone. Approximately one in four adults, equal to about 15 million people, experience severe joint pain due to arthritis, and non-steroidal anti-inflammatory drugs are commonly used to manage this chronic pain and heal related injuries. This spike in chronic pain prevalence propels the growth of the non-steroidal anti-inflammatory drugs market.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp
Who Are The Key Players Driving Non-Steroidal Anti-inflammatory Drugs Market Growth?
• Pfizer Inc.
• Bayer AG
• Johnson & Johnson
• Sun Pharmaceutical Industries Ltd.
• Assertio Therapeutics Inc.
• Iroko Pharmaceuticals Inc.
• Reckitt Benckiser Group PLC
• Perrigo Company PLC
• Hikma Pharmaceuticals Public Limited Company
• Glenmark Pharmaceuticals Limited
• Septodont, Aspen Pharmacare Holdings Limited
• Sagent Pharmaceuticals Inc.
• Advanced Pharma Inc.
• Akorn Operating Company LLC
• Alembic Pharmaceuticals Limited
• Torrent Pharmaceuticals Limited
• Lupin Limited
• Cipla Limited
• Zydus Cadila Healthcare Limited
• Aurobindo Pharma Limited
• Sanofi S.A.
• GlaxoSmithKline PLC
• Horizon Therapeutics PLC
• Zyla Life sciences
• Novartis AG
• Roche Holding AG
• AbbVie Inc.
• Bristol-Myers Squibb Company
What Are The Key Trends In The Non-Steroidal Anti-inflammatory Drugs Market?
• Dominance of the over-the-counter (OTC) market
• Rising preference for COX-2 inhibitors
• Intense competition from generics
• Integration of digital health technologies
What Are The Segments Of The Global Non-Steroidal Anti-inflammatory Drugs Market?
• Route Of Administration: Oral, Topical, Other Route of Administration
• Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
• Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Which Region Leads The Non-Steroidal Anti-inflammatory Drugs Market?
In 2024, North America was the largest region in the non-steroidal anti-inflammatory drugs market. However, Asia-Pacific is forecast to be the fastest-growing region in the upcoming years. Other regions covered in the report are Western Europe, Eastern Europe, South America, Middle East, and Africa.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report
What Is Covered In The Non-Steroidal Anti-inflammatory Drugs Market Global Market Report?
- Market Size Analysis: Analyze the Non-Steroidal Anti-inflammatory Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Non-Steroidal Anti-inflammatory Drugs Market for effective categorization.
- Key Player Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Non-Steroidal Anti-inflammatory Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Non-Steroidal Anti-inflammatory Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=ds
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company, with over 15,000+ reports from 27 industries spanning 60+ geographies, stands as a trusted source of comprehensive, data-rich research and insights. Equipped with 1,500,000 datasets, the unique blend of in-depth secondary research, and insights from industry leaders empowers you to stay ahead. Explore our flagship product, the Global Market Model (GMM), to leverage comprehensive and cutting-edge forecasts for informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Surge in the Global Non-Steroidal Anti-Inflammatory Drugs Market: A Comprehensive Review of Market Size, Market Share, Growth Drivers, and Upcoming Trends here
News-ID: 3821996 • Views: …
More Releases from The Business research company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
